Pine River Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-435,171
Closed -$33.5M 743
2015
Q4
$33.5M Sell
435,171
-629,228
-59% -$47.4M 0.45% 42
2015
Q3
$71.3M Sell
1,064,399
-21,395
-2% -$1.58M 0.91% 15
2015
Q2
$80.5M Sell
1,085,794
-36,824
-3% -$2.81M 0.88% 19
2015
Q1
$87.6M Buy
1,122,618
+191,429
+21% +$14.5M 1.06% 19
2014
Q4
$67.2M Sell
931,189
-974,350
-51% -$67.7M 0.86% 28
2014
Q3
$118M Buy
1,905,539
+321,728
+20% +$20.5M 1.38% 9
2014
Q2
$101M Buy
1,583,811
+1,350,879
+580% +$82.1M 1.56% 9
2014
Q1
$14.3M Buy
232,932
+13,123
+6% +$764K 0.22% 116
2013
Q4
$12.6M Buy
219,809
+158,010
+256% +$8.96M 0.15% 165
2013
Q3
$3.29M Buy
61,799
+41,917
+211% +$2.26M 0.04% 315
2013
Q2
$1.02M Buy
+19,882
New +$983K 0.02% 369

Other funds holding MDT

Pine River Capital Management's MDT Position: Q1 2016 in Review

Pine River Capital Management sold out of Medtronic (MDT) in Q1 2016, closing a stake of 435,171 shares — an estimated $33.5M sold.

Pine River Capital Management first reported a position in MDT in Q2 2013 and held it in 11 quarters. The position peaked at $118M in Q3 2014. 1,240 funds tracked by Wall St. Rank hold MDT as of Q1 2016.

  • Pine River Capital Management reported no remaining Medtronic position as of Q1 2016 after selling out during the quarter.
  • Pine River Capital Management sold 435,171 Medtronic shares in Q1 2016, an estimated $33.5M.
  • Pine River Capital Management first reported a position in Medtronic in Q2 2013 and held it in 11 quarters.
  • Pine River Capital Management's Medtronic position peaked at $118M in Q3 2014.
  • 1,240 funds tracked by Wall St. Rank held Medtronic as of Q1 2016.

Based on Pine River Capital Management's 13F filing for Q1 2016, filed 16 May 2016.